Details for New Drug Application (NDA): 009176
✉ Email this page to a colleague
NDA 009176 describes CORTRIL, which is a drug marketed by Pfizer, Pfizer Global, and Pfipharmecs, and is included in four NDAs. Additional details are available on the CORTRIL profile page.
The generic ingredient in CORTRIL is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
The generic ingredient in CORTRIL is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 009176
| Tradename: | CORTRIL |
| Applicant: | Pfizer Global |
| Ingredient: | hydrocortisone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009176
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 2.5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
